当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析

艾德生物

(300685)

  

流通市值:78.23亿  总市值:78.33亿
流通股本:3.90亿   总股本:3.90亿

艾德生物(300685)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.85亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益205760.26万元,未分配利润147871.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产239691.23万元,负债33930.98万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入260,346,165.811,197,733,641.14865,632,981.04579,344,557.65
营业总成本168,270,302.9784,423,277.66560,748,986.69358,787,743.26
其他经营收益
营业利润98,055,121.45417,426,251.86306,392,696.26222,738,181.68
利润总额95,891,418.97410,920,550.46300,817,448.37219,509,851.42
净利润85,156,924.42361,255,321.05262,505,939.1189,037,382.96
每股收益
其他综合收益-125,146.33106,770.0256,175.38
综合收益总额85,156,924.42361,380,467.38262,612,709.12189,093,558.34
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,110,689,965.812,052,938,923.641,995,678,659.231,920,009,529.97
非流动资产:
非流动资产合计286,222,356.13294,696,462.69250,496,885.42273,813,226.65
资产总计2,396,912,321.942,347,635,386.332,246,175,544.652,193,822,756.62
流动负债:
流动负债合计139,396,813178,118,020.46182,725,828.21225,025,173.42
非流动负债:
非流动负债合计199,912,944.15113,570,961.6104,527,586.0283,134,401.27
负债合计339,309,757.15291,688,982.06287,253,414.23308,159,574.69
所有者权益(或股东权益):
归属于母公司股东权益合计2,057,602,564.792,055,946,404.271,958,922,130.421,885,663,181.93
股东权益合计2,057,602,564.792,055,946,404.271,958,922,130.421,885,663,181.93
负债和股东权益合计2,396,912,321.942,347,635,386.332,246,175,544.652,193,822,756.62
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计341,274,557.111,252,647,501.42916,140,935.3577,134,919.71
经营活动现金流出小计233,986,599.88887,823,441.91640,754,341.83406,551,636.56
经营活动产生的现金流量净额107,287,957.23364,824,059.51275,386,593.47170,583,283.15
投资活动产生的现金流量:
投资活动现金流入小计153,105,337.5293,828,146.14268,871,410.51203,395,060.45
投资活动现金流出小计331,794,983.25525,725,831.17393,551,988.29234,630,370.7
投资活动产生的现金流量净额-178,689,645.75-231,897,685.03-124,680,577.78-31,235,310.25
筹资活动产生的现金流量:
筹资活动现金流入小计94,000,000101,678,234.690,153,559.3665,129,357.98
筹资活动现金流出小计85,835,898.13203,381,280.86199,158,713.7172,727,465.51
筹资活动产生的现金流量净额8,164,101.87-101,703,046.26-109,005,154.34-107,598,107.53
汇率变动对现金及现金等价物的影响-12,942,140.83-5,142,146.983,602,104.049,345,925.35
现金及现金等价物净增加额-76,179,727.4826,081,181.2445,302,965.3941,095,790.72
期末现金及现金等价物余额265,363,289.58341,543,017.06360,764,801.21356,557,626.54
补充资料:
现金及现金等价物的净增加额-26,081,181.24-41,095,790.72
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
光大证券黎一江1.101.301.532026-04-29
中信证券宋硕,陈竹,李文涛1.061.181.282026-04-24
信达证券唐爱金1.071.271.542026-04-22
中国银河孟熙,程培1.091.271.472026-04-16
中金公司俞波,张琎,陈诗雨0.911.081.252026-03-13
TOP↑